Pfizer acquisition of cancer drug company could advance oncology research

Published Online: Aug 23,2016 Laurie Toich, Assistant Editor Pfizer recently announced its plans to acquire Medivation, a biopharmaceutical company that develops molecules for oncology. Recent health insurer mergers could have deterred the $14 billion deal, but Pfizer and Medivation’s boards of directors approved the merger, and expect that shares will increase immediately, according to a press release from Pfizer. “The proposed …

Download White Paper : Translating Cancer Genomics for personalized approach to treating cancer

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.The study of cancer genomics has …

NHS faces backlash over Cancer Drugs Fund treatments changes

NHS England announced this week a decision to reassess 42 drugs that are available as part of the Cancer Drugs Fund. The decision comes as a result of current spending expected to be £100m over the initial budget of £280m for this financial year. With the current system viewed as unsustainable, price caps have been brought in for the first time …

Almost half of cancer patients are diagnosed in late stages

Analysis by Cancer Research UK, released on Monday 22 September, concluded that 46% of cancers in England are diagnosed in the advanced stages. Given the importance of early diagnosis, this would indicates that almost half of cancer patients are diagnosed at a point when treatment will no longer be truly effective. The report, conducted by Incisive Health for CRUK, indicated …

E-Clinical Solution Market Predicted To Reach $5 Billion by 2018

A new report by Persistence Market Research has suggested that the global e-clinical solution software market was estimated to grow at a CAGR of 13.8% from 2014 to 2020, indicating significant growth within the sector. The e-clinical solution software market provides software to analyse clinical data, which is ever increasing with more and more clinical trials occurring. The need for …

Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

Can Gold Fight Cancer?

Exciting developments have gripped the cancer research space as a result of a “Trojan horse” treatment for Glioblastoma Multiforme, an extremely aggressive form of brain cancer which sees a devastating survival rate at just six in every 100 patients making it past the 5-year mark. This form of brain cancer is notorious as adults rarely survive past the first months of diagnosis. …

The Story of Digital Health

This is the story of DigiHealth. Three years ago I was living in New York, managing a team and portfolio of pharmaceutical conferences throughout America. One day, having gone to the dentist to have a particularly painful wisdom tooth examined, a scan revealed that I had a malignant tumour in my left cheek. What followed was a painful and genuinely …

Hunterdon Regional Cancer Center: The Only Cancer Center in New Jersey to Offer Immuno-Therapy Clinical Trial for Lung Cancer

June 11 2014: According to the American Cancer Society, lung cancer is the second most common cancer among men and women and the leading cause of death in the United States. In 2014, it is estimated that 224,210 people will be diagnosed with lung cancer. Hunterdon Regional Cancer Center was selected as the only cancer facility in New Jersey to offer a clinical …